Reuters, December 29, 2011. With the scandal surrounding France’s Poly Implant Prothese (PIP), questions arise whether there should be a national or worldwide breast implant registry.
Washington Post. November 19, 2011. “The science is clear: Breast cancer patients are more likely to be harmed than helped by Avastin,” said Diana Zuckerman, president of the National Research Center for Women & Families. “The risks of the drug are very substantial and can be fatal, killing patients long before they would otherwise die from the disease. FDA made a scientific decision, and it was absolutely the right decision.”
NRC President, Dr. Diana Zuckerman, tells AP about the problems with Avastin.
Dana Casciotti, the public health research director of the Cancer Prevention and Treatment Fund testifies at an FDA advisory meeting on breast implants.
Cancer Prevention and Treatment Fund president, Dr. Diana Zuckerman, testifies at an FDA advisory meeting on breast implants.